logo

Slide Shows

Share
Events

Do You Own These Cannabis Stocks? Legal cannabis was one of the dominating headlines in 2018. Canada’s legalization of marijuana for recreational use, legalization of recreational and medicinal marijuana in a number of U.S states, and FDA approval of the first cannabis-based medication, Epidiolex, to treat rare, severe forms of epilepsy have galvanized interests and investments in this sector.

Biotech Stocks Facing FDA Decision In May 2019 A lot happened in the month of April, from the resignation of FDA Commissioner Scott Gottlieb coming into effect, approval of the first targeted therapy for metastatic bladder cancer, market clearance of the first medical device for treatment of ADHD, approval of the first generic naloxone nasal spray to treat opioid overdose to the launch of the world’s first malaria vaccine.

Massive job cuts in 2019 Job cuts mean a reduction in the number of jobs in a company, area or a country. A single person could be fired from his job due to his job performance, unethical behaviour, or personality differences. But layoffs usually occur with more than one worker for impersonal reasons, such as business or economic decisions. The most common reason for layoffs is because companies need to cut costs due to the absence of profits or on falling sales. Mergers and acquisitions of companies may also result in layoffs, as overlap in some areas may lead to the decision to eliminate positions. In addition, overstaffing, a change in roles, or outsourcing could result in job losses at companies. The elimination of redundant tasks may also lead to job losses.

Biotech Stocks Facing FDA Decision In April So far this year, 4 novel drugs have been approved in the U.S., including Zulresso. Now, let's take a look at the companies that await a ruling from the FDA in April 2019.